Alvotech and LOTTE Biologics Sign US Manufacturing Deal
Alvotech and LOTTE Biologics have signed a US manufacturing deal for multiple biosimilars, expanding global manufacturing capacity at LOTTE’s Syracuse facility.
Manufacturing Agreement | 07/10/2026 | By News Bureau
Pluri and Remedy Cell Expand Partnership with Clinical-Grade Manufacturing Success
The duo have integrated Remedy Cell’s proprietary manufacturing process into Pluri’s GMP facility, completed GMP training and qualification for Remedy Cell’s manufacturing team, conducted engineering runs to validate process robustness and scalability, and produced multiple clinical-grade batches of Remedy Cell's lead candidate.
Manufacturing Agreement | 23/12/2025 | By News Bureau | 235
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy